EKF Diagnostics Holdings (EKF)

Sector:

Financials

Index:

FTSE AIM All-Share

0.000p
   
  • Closing Price Chg:
      2.00p
  • 52 Week High: 32.00p
  • 52 Week Low: 19.00p
  • Currency: UK Pounds
  • Shares Issued: 433.83m
  • Volume: 0
  • Beta: 0.12

EKF Overview

EKF Diagnostics is a global medical manufacturer of point-of-care and central lab devices and chemistry reagents including hemoglobin tests, HbA1c tests, glucose and lactate tests.
Competitors: Physiomics, SDI Group , Polarean Imaging
Registrars: Capita Registrars

Key Personnel

CEO: Gavin T Jones
CFO: Stephen (Steve) Young
Executive Chairman: Julian Baines
Senior Independent Director: Christian Alexander Rigg
Non-Executive Dir: Jenny Winter, Christopher H B Mills

Contact Details

Address: Avon House, 19 Stanwell Road, Penarth, Cardiff, United Kingdom, CF64 2EZ
Phone: +44 (0)29 20 710570
Fax: +44 (0)29 20 705715
Website: http://www.ekfdiagnostics.com

Listings

Sector: Financials(LSE)
Index: FTSE AIM All-Share
ISIN: GB0031509804

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

EKF Market Data

Currency UK Pounds
Share Price 27.00p
Closing Price Change 2.00p
% Change 0.00 %
52 Week High 32.00p
52 Week Low 19.00p
Volume 0
Shares Issued 433.83m
Beta 0.12

EKF Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
90.32% below the market average90.32% below the market average90.32% below the market average90.32% below the market average90.32% below the market average
89.8% below the sector average89.8% below the sector average89.8% below the sector average89.8% below the sector average89.8% below the sector average
Price Trend
12.36% above the market average12.36% above the market average12.36% above the market average12.36% above the market average12.36% above the market average
28.71% below the sector average28.71% below the sector average28.71% below the sector average28.71% below the sector average28.71% below the sector average
Income Not Available
Growth
61.17% above the market average61.17% above the market average61.17% above the market average61.17% above the market average61.17% above the market average
59.14% above the sector average59.14% above the sector average59.14% above the sector average59.14% above the sector average59.14% above the sector average

EKF Dividends

  Latest Previous
  Final Final
Ex-Div 02-Nov-23 03-Nov-22
Paid 01-Dec-23 01-Dec-22
Amount 1.20p 1.20p

Trades for --2026

Time Volume / Share Price
0 @ 0.000p

EKF Key Personnel

CFO Stephen (Steve) Young
CEO Gavin T Jones

Top of Page